|
Date of decision
|
26 February 1999
|
|
|
Case number
|
T 0317/95
- 3.3.2
|
|
|
Application number
|
88200397.3
|
|
|
|
|
|
|
Title of the application
|
Compositions and their use for treating gastrointestinal
disorders
|
|
|
Applicant name
|
The Procter & Gamble Company
|
|
|
Opponent name
|
01: Glaxo Group Limited
02: SmithKline Beecham plc.
|
|
|
|
|
Keywords
Novelty and patentability under Article 52(4) EPC:
(questionable)
Inventive step: (no), obvious modification in relation to
simplification and patient's compliance
|
|
|
|
Catchwords:
|
|
Use claims directed to the second medical use of two known drugs
- treatment by concurrent administration differing from
treatment in the prior art by the prescribed regimen (see
reasons No. 4).
|
|
|
